Logo image of PRHI

PRESURANCE HOLDINGS INC (PRHI) Stock Fundamental Analysis

USA - NASDAQ:PRHI - US20731J1025 - Common Stock

1.41 USD
+0.01 (+0.71%)
Last: 10/16/2025, 8:10:00 PM
1.5388 USD
+0.13 (+9.13%)
After Hours: 10/16/2025, 8:10:00 PM
Fundamental Rating

2

PRHI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 145 industry peers in the Insurance industry. PRHI may be in some trouble as it scores bad on both profitability and health. PRHI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year PRHI was profitable.
PRHI had a negative operating cash flow in the past year.
In multiple years PRHI reported negative net income over the last 5 years.
In multiple years PRHI reported negative operating cash flow during the last 5 years.
PRHI Yearly Net Income VS EBIT VS OCF VS FCFPRHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.66%, PRHI belongs to the top of the industry, outperforming 97.93% of the companies in the same industry.
PRHI's Return On Equity of 107.03% is amongst the best of the industry. PRHI outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 10.66%
ROE 107.03%
ROIC N/A
ROA(3y)-1.09%
ROA(5y)-0.69%
ROE(3y)-281.43%
ROE(5y)-169.13%
ROIC(3y)N/A
ROIC(5y)N/A
PRHI Yearly ROA, ROE, ROICPRHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

The Profit Margin of PRHI (48.11%) is better than 100.00% of its industry peers.
PRHI does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 48.11%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PRHI Yearly Profit, Operating, Gross MarginsPRHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

1

2. Health

2.1 Basic Checks

PRHI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PRHI remains at a similar level compared to 1 year ago.
The number of shares outstanding for PRHI has been increased compared to 5 years ago.
The debt/assets ratio for PRHI has been reduced compared to a year ago.
PRHI Yearly Shares OutstandingPRHI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
PRHI Yearly Total Debt VS Total AssetsPRHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

PRHI has a Debt/Equity ratio of 0.64. This is a neutral value indicating PRHI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.64, PRHI is doing worse than 81.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC13.68%
PRHI Yearly LT Debt VS Equity VS FCFPRHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
PRHI Yearly Current Assets VS Current LiabilitesPRHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 220.03% over the past year.
PRHI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -36.73%.
PRHI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.87% yearly.
EPS 1Y (TTM)220.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%152.44%
Revenue 1Y (TTM)-36.73%
Revenue growth 3Y-13.6%
Revenue growth 5Y-6.87%
Sales Q2Q%-39.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y171.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PRHI Yearly Revenue VS EstimatesPRHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
PRHI Yearly EPS VS EstimatesPRHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1 -2 -3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

PRHI is valuated cheaply with a Price/Earnings ratio of 0.55.
Based on the Price/Earnings ratio, PRHI is valued cheaply inside the industry as 98.62% of the companies are valued more expensively.
PRHI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.31.
With a Price/Forward Earnings ratio of 27.65, PRHI can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PRHI indicates a slightly more expensive valuation: PRHI is more expensive than 77.24% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of PRHI to the average of the S&P500 Index (22.85), we can say PRHI is valued slightly more expensively.
Industry RankSector Rank
PE 0.55
Fwd PE 27.65
PRHI Price Earnings VS Forward Price EarningsPRHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRHI Per share dataPRHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

PRHI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PRHI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PRESURANCE HOLDINGS INC

NASDAQ:PRHI (10/16/2025, 8:10:00 PM)

After market: 1.5388 +0.13 (+9.13%)

1.41

+0.01 (+0.71%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners31.83%
Inst Owner ChangeN/A
Ins Owners11.1%
Ins Owner Change-100%
Market Cap17.23M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.04
Dividend Growth(5Y)N/A
DP0.36%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.41%
Min Revenue beat(2)-36.48%
Max Revenue beat(2)-16.34%
Revenue beat(4)1
Avg Revenue beat(4)-4.07%
Min Revenue beat(4)-36.48%
Max Revenue beat(4)53.4%
Revenue beat(8)5
Avg Revenue beat(8)9.31%
Revenue beat(12)6
Avg Revenue beat(12)5.25%
Revenue beat(16)7
Avg Revenue beat(16)1.88%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.55
Fwd PE 27.65
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 0.61
EV/EBITDA N/A
EPS(TTM)2.56
EY181.56%
EPS(NY)0.05
Fwd EY3.62%
FCF(TTM)-3.99
FCFYN/A
OCF(TTM)-3.99
OCFYN/A
SpS5.14
BVpS2.31
TBVpS2.31
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.66%
ROE 107.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 48.11%
GM N/A
FCFM N/A
ROA(3y)-1.09%
ROA(5y)-0.69%
ROE(3y)-281.43%
ROE(5y)-169.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC13.68%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)220.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%152.44%
EPS Next Y171.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-36.73%
Revenue growth 3Y-13.6%
Revenue growth 5Y-6.87%
Sales Q2Q%-39.91%
Revenue Next Year7%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-22.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-84.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.29%
OCF growth 3YN/A
OCF growth 5YN/A